Heat Biologics highlighted Importance of T cell immunity to prevent COVID-19
On Aug. 5, 2020, Heat Biologics highlighted the importance of T cell immunity in preventing COVID-19 in a…
-
-
Johnson & Johnson announces agreement with US Government for 100 million doses of investigational COVID-19 vaccine
On Aug. 5, 2020, Johnson & Johnson announced a $1 billion agreement with the U.S. government for the…
-
Pfizer and BioNTech to supply Canada with their BNT162 mRNA- based vaccine candidate
On Aug. 5, 2020, Pfizer Canada and BioNTech announced an agreement with the Government of Canada to supply…
-
AXIM Biotechnologies applied for FDA Emergency Use Approval for high throughput, neutralizing antibody diagnostic test for COVID-19
On Aug. 5, 2020, AXIM Biotechnologies announced the development, patent filing and Emergency Use Approval (EUA) filing of…
-
HKUMed researchers first discovered SARS-CoV-2 infects human neural progenitor cells and brain organoids
On Aug. 4, 2020, researchers at The University of Hong Kong (HKUMed) collaborated with researchers at the Institute…
-
Innovation Pharma and US Regional Biocontainment Laboratory updated brilacidin anti-SARS-CoV-2 in vitro testing
On Aug. 4, 2020, Innovation Pharma reported receiving an update from a U.S. Regional Biocontainment Laboratory (RBL) based…
-
Bio-Techne and Kantaro Biosciences to launch a quantitative research use only COVID-19 serology test
On Aug. 3, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
-
Pathnova Laboratories announced partnership to commercialize Todos Medicals COVID-19 and breast cancer tests in Singapore
On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…
-
ImmunityBio study showed positive T cell and antibody immune responses to its COVID-19 vaccine candidate
On Aug. 3, 2020, ImmunityBio announced positive preclinical results for its human Ad5 vaccine candidate that contains both…
-
La Jolla Institute for Immunology received $1 million from GHR Foundation in support of COVID-19 research
On Aug. 3, 2020, the La Jolla Institute for Immunology (LJI) announced a $1 million gift from GHR…
-
Lilly initiated phase 3 trial of LY-CoV555 for prevention of COVID-19 at lLong-term care facilities in partnership with NIAID
On Aug. 3, 2020, Eli Lilly announced the initiation of BLAZE-2, a phase 3 trial studying LY-CoV555 for…
-
NIH delivered new COVID-19 testing technologies to meet US demand
On Jul. 31, 2020, the NIH announced that it had invested $248.7 million in new technologies to address…
-
Biotechnology | COVID-19 | NIH
Quidel received NIH contract for $71 million to expand manufacturing capacity for Sofia SARS-CoV-2 antigen test for diagnosis of COVID-19
On Jul. 31, 2020, Quidel announced a preliminary contract with the NIH to support the expansion of its…
-
COVID-19 | Diagnostics | NIH
Mesa Biotech announced $154 million funding from the NIH for Accelerated scale-up and deployment
On Jul. 31, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
-
Pfizer and BioNTech announced an agreement with the MHLW in Japan to supply 120 million doses of BNT162 mRNA-based vaccine candidate
On Jul. 31, 2020, Pfizer and BioNTech announced an agreement with the Ministry of Health, Labour and Welfare…
-
OraSure’s OMNIgene-ORAL device included in EUA granted to Clinical Reference Laboratory for self-collected SARS saliva test
On Jul. 31, 2020, OraSure Technologies announced that its OMNIgene-ORAL (OM-505) saliva collection device is included in the…
-
RedHill Biopharma initiated global phase 2/3 study for COVID-19
On Jul. 30, 2020, RedHill Biopharma announced that it has initiated a global Phase 2/3 clinical study evaluating…
-
BD announced $24 million US Government investment to support scale up of US manufacturing of COVID-19 diagnosic tests
On Jul. 30, 2020, BD (Becton, Dickinson) announced a $24 million investment from the U.S. Department of Defense…
-
Single dose of Johnson & Johnson COVID-19 vaccine candidate demonstrated robust protection in pre-clinical studies
On Jul. 30, 2020, Johnson & Johnson announced that its lead vaccine candidate protected against infection with SARS-CoV-2,…
-
INOVIO’s COVID-19 DNA vaccine INO-4800 provided protection with memory immune responses In non-human primates challenged with SARS-CoV-2 virus
On Jul. 30, 2020, INOVIO announced that its COVID-19 DNA vaccine INO-4800 targeting SARS-CoV-2 was effective in protecting…
-
Intravacc and Celonic to develop and produce a novel COVID-19 vaccine
On Jul. 29, 2020, Intravacc and Celonic Group, a biopharmaceutical contract development and manufacturing organization (CDMO), announced that…
-
Veracyte and MAVIDx announcd agreement for MAVIDx to develop ultra-high volume COVID-19 testing on the nCounter System
On Jul. 29, 2020, Veracyte and MAVIDx announced an agreement for MAVIDx to develop ultra-high throughput genomic testing…
-
Heat Biologics COVID-19 vaccine demonstrated immunogenicity proof-of-concept in pre-clinical studies
On Jul. 29, 2020, Heat Biologics announced successful pre-clinical testing of the Company’s COVID-19 vaccine, which demonstrated in-vivo…
-
Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccine
On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax program (heat stable COVID-19…
-
Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccine
On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax™ program (heat stable COVID-19…
-
Experimental COVID-19 vaccine protected upper and lower airways in nonhuman primates
On Jul. 28, 2020, scientists at the National Institute of Allergy and Infectious Diseases reported that two doses…
-
Moderna announced publication in the NEJM of non-human primate preclinical viral challenge study of its mRNA vaccine against COVID-19
On Jul. 28, 2020, Moderna announced a preclinical study evaluating mRNA-1273, its vaccine candidate against COVID-19, was published…
-
MediciNova announced SARS-CoV-2 vaccine joint development with BioComo and Mie University Japan
On Jul. 27, 2020, MediciNova announced an agreement with BioComo and Mie University (Mie prefecture, Japan) for joint…
-
Biotechnology | COVID-19 | FDA
Dynavax and Medigen announced collaboration to develop a novel adjuvanted COVID-19 vaccine candidate
On Jul. 23, 2020, Dynavax Technologies and Medigen Vaccine Biologics announced their collaboration to develop an adjuvanted vaccine…
-
AXIM Biotechnologies released Rapid NeuCovix test results showing strong agreement with COVID-19-based neutralization tests
On Jul. 23, 2020, AXIM Biotechnologies announced development of NeuCovixTM, a rapid diagnostic test measuring levels of functional…
